CCL2 and anemia (phenotype): The current pilot study found a positive association between plasma MCP-1 levels, angiogenesis (expressed as TVA), and the main clinical features of MM (i.e., bone disease, renal dysfunction, and anemia) in newly diagnosed MM patients.